Back
ESC Premium Access

Residual stroke risk of anticoagulated patients with atrial fibrillation: PREFER in AF European registry.

Session: Poster session 5 - Registries and cost of treatment
Topic: Atrial fibrillation (AF)
Speaker: Doctor M. Rohla (Bern, CH)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Miklos Rohla

Bern University Hospital, Inselspital, Bern (Switzerland)
0 follower

11 more presentations in this session

Global healthcare resource use in 39,670 patients with AF: perspectives from GARFIELD-AF

Speaker: Mr P. Cozzolino (Monza, IT)

Access
Abstract
Slides
Like
Thumbnail

Economic evaluation of alternative anticoagulants for the stroke prevention in the patients with atrial fibrillation

Speaker: Miss M. Lee (Tainan, TW)

Access
Abstract
Like
Thumbnail

Cost-effectiveness analysis of a handheld ECG machine used for a population-wide screening programme: the Belgian Heart Rhythm Week Screening programme

Speaker: Associate Professor M. Proietti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Health-related quality of life change after thoracoscopic surgery for advanced atrial fibrillation: results of the AFACT study

Speaker: Doctor W. Berger (Amsterdam, NL)

Access
Abstract
Like
Thumbnail

Incident atrial fibrillation and the risk of stroke in patients with chronic kidney disease

Speaker: Doctor K. Szummer (Stockholm, SE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 5 - Registries and cost of treatment

Speakers: Doctor M. Rohla, Mr P. Cozzolino, Miss M. Lee, Associate Professor M. Proietti, Doctor W. Berger...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources